The UMass CFAR Clinical Core's mission is to provide the infrastructure and services that promote innovative patient-oriented and translational HIV research. The CFAR Clinical Core has the following goals: 1) To facilitate interactions between basic scientists and clinical investigators that lead to patient-oriented studies that improve our understanding of HIV pathogenesis and the development of novel prevention or treatment strategies;2) To provide the necessary expertise and services to facilitate patient-oriented and translational research;3) To coordinate services with other CFAR Core Laboratories;4) To support the training and advancement of new investigators in HIV-related research;and 5) To provide community education regarding HIV and UMass CFAR Clinical HIV Research. The Clinical Core consists of a Clinical Sciences Core and a Clinical Immunology Core. The Clinical Sciences Core provides services that support the design, implementation, and analysis of patient-oriented and translational research with the goals of streamlining investigator training and protocol development. Other services provided by the Clinical Sciences Core include specimen receipt, processing, storage, and shipment;maintenance of extensive, integrated clinical (adult and pediatric) and laboratory databases;and a Bio-Statistics Sub-Core to provide statistical consultation for grant preparation, data analysis, and publications. The Clinical Immunology Core provides protocols, reagents, and services in support of patient-oriented and translational research. In addition, the UMass CFAR Clinical Core has recently partnered with the UMass Flow Cytometry Core to develop a Biosafety Level 3 Flow Cytometry and Sorting Facility. Over the next funding period, the Clinical Core will work with CFAR investigators and other CFAR Cores to provide services supporting studies that improve our understanding of HIV pathogenesis and strategies to prevent or treat HIV-1 infection.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-EC-A)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Massachusetts Medical School Worcester
United States
Zip Code
Ambade, Aditya; Satishchandran, Abhishek; Szabo, Gyongyi (2016) Alcoholic hepatitis accelerates early hepatobiliary cancer by increasing stemness and miR-122-mediated HIF-1? activation. Sci Rep 6:21340
Peters, Paul J; Gonzalez-Perez, Maria Paz; Musich, Thomas et al. (2015) Infection of ectocervical tissue and universal targeting of T-cells mediated by primary non-macrophage-tropic and highly macrophage-tropic HIV-1 R5 envelopes. Retrovirology 12:48
Fouda, Genevieve G; Cunningham, Coleen K; McFarland, Elizabeth J et al. (2015) Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses. J Infect Dis 211:508-17
Musich, Thomas; O'Connell, Olivia; Gonzalez-Perez, Maria Paz et al. (2015) HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages. Retrovirology 12:25
Gibson, Laura; Barysauskas, Constance M; McManus, Margaret et al. (2015) Reduced frequencies of polyfunctional CMV-specific T cell responses in infants with congenital CMV infection. J Clin Immunol 35:289-301
Greenough, Thomas C; Straubhaar, Juerg R; Kamga, Larisa et al. (2015) A Gene Expression Signature That Correlates with CD8+ T Cell Expansion in Acute EBV Infection. J Immunol 195:4185-97
Brehm, Michael A; Wiles, Michael V; Greiner, Dale L et al. (2014) Generation of improved humanized mouse models for human infectious diseases. J Immunol Methods 410:3-17
Luzuriaga, Katherine; Tabak, Barbara; Garber, Manuel et al. (2014) HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatment. J Infect Dis 210:1529-38
Usami, Yoshiko; Göttlinger, Heinrich (2013) HIV-1 Nef responsiveness is determined by Env variable regions involved in trimer association and correlates with neutralization sensitivity. Cell Rep 5:802-12
Covassin, L; Jangalwe, S; Jouvet, N et al. (2013) Human immune system development and survival of non-obese diabetic (NOD)-scid IL2r?(null) (NSG) mice engrafted with human thymus and autologous haematopoietic stem cells. Clin Exp Immunol 174:372-88

Showing the most recent 10 out of 121 publications